IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

被引:3149
作者
Langrish, CL
Chen, Y
Blumenschein, WM
Mattson, J
Basham, B
Sedgwick, JD
McClanahan, T
Kastelein, RA
Cua, DJ
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Discovery Res, Palo Alto, CA 94304 USA
[2] DNAX Res Inst Mol & Cellular Biol Inc, Expt Pathol & Pharmacol, Palo Alto, CA 94304 USA
[3] DNAX Res Inst Mol & Cellular Biol Inc, Bioinformat, Palo Alto, CA 94304 USA
关键词
D O I
10.1084/jem.20041257
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-23 is a heterodimeric cytokine composed of a unique p19 subunit, and a common p40 subunit shared with IL-12. IL-12 is important for the development of T helper (Th)1 cells that are essential for host defense and tumor suppression. In contrast, IL-23 does not promote the development of interferon-gamma-producing Th1 cells, but is one of the essential factors required for the expansion of a pathogenic CD4(+) T cell population, which is characterized by the production of IL-17, IL-17F, IL-6, and tumor necrosis factor. Gene expression analysis of IL-23-driven autoreactive T cells identified a unique expression pattern of proinflammatory cytokines and other novel factors, distinguishing them from IL-12-driven T cells. Using passive transfer studies, we confirm that these IL-23-dependent CD4(+) T cells are highly pathogenic and essential for the establishment of organ-specific inflammation associated with central nervous system autoimmunity.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 36 条
  • [1] Aarvak T, 1999, J IMMUNOL, V162, P1246
  • [2] Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
    Aggarwal, S
    Ghilardi, N
    Xie, MH
    de Sauvage, FJ
    Gurney, AL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1910 - 1914
  • [3] Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
  • [4] RETRACTED: The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies (Retracted Article)
    Airoldi, I
    Di Carlo, E
    Banelli, B
    Moserle, L
    Cocco, C
    Pezzolo, A
    Sorrentino, C
    Rossi, E
    Romani, M
    Amadori, A
    Pistoia, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) : 1651 - 1659
  • [5] Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
    Becher, B
    Durell, BG
    Noelle, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (04) : 493 - 497
  • [6] Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
    Cua, DJ
    Sherlock, J
    Chen, Y
    Murphy, CA
    Joyce, B
    Seymour, B
    Lucian, L
    To, W
    Kwan, S
    Churakova, T
    Zurawski, S
    Wiekowski, M
    Lira, SA
    Gorman, D
    Kastelein, RA
    Sedgwick, JD
    [J]. NATURE, 2003, 421 (6924) : 744 - 748
  • [7] Development of anti-TNF therapy for rheumatoid arthritis
    Feldmann, M
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (05) : 364 - 371
  • [8] Ferber IA, 1996, J IMMUNOL, V156, P5
  • [9] Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice
    Ghilardi, N
    Kljavin, N
    Chen, Q
    Lucas, S
    Gurney, AL
    de Sauvage, FJ
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (05) : 2827 - 2833
  • [10] IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination
    Gran, B
    Zhang, GX
    Yu, S
    Li, JF
    Chen, XH
    Ventura, ES
    Kamoun, M
    Rostami, A
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (12) : 7104 - 7110